LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis.

Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y. · 2020

Read LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. by Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7347613.txt.

Description

Arra and co-authors present a research article in Nature Communications on osteoarthritis. It asks how inflammation helps drive cartilage loss in the joint. The focus is cartilage cells, called chondrocytes, under inflammatory stress. A metabolic shift sits at the center of the work.

The authors show that inflammation switches these cells toward sugar-based energy use. A protein switch called NF-kB drives that change. The shift raises an enzyme, LDHA, which boosts reactive oxygen species in the cell. Those species steady a pro-inflammatory mediator that pushes cartilage breakdown. Blocking this path could slow joint damage, the authors suggest. They name LDHA as a possible drug target. Readers get a clear chain from inflammation to cartilage loss.

Catalog record

CREATORArra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X, Maruyama T, Rai MF, O'Keefe RJ, Mbalaviele G, Shen J, Abu-Amer Y.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7347613

Browse the full library · About the Tower of Babel